|Series A, 3/10 ||$4.55M|
|Series B, 6/11 ||$5.8M|
Adaptive TCR Corporation’s platform technology breaks open the field of genomics immunology. T-cell receptor profiling using Adaptiveâ€™s proprietary technology and software allows scientists to study the adaptive immune system to an unprecedented depth via high-throughput T-Cell Receptor (TCR) sequencing. Adaptive provides T-cell receptor profiling as a service to the research community.
The Adaptive team is developing a myriad of applications based on this technology, such as the study of immune system reconstitution post-bone marrow transplantation and the efficacy of vaccines in development. Adaptive is pioneering work using this technology to discover diagnostics in immune system disorders, such as Multiple Sclerosis and Type I Diabetes.